Meeting
2022 ASCO Annual Meeting
Breath biopsy early detection of lung cancer using an EVOC probe targeting tumor-specific extracellular β-glucuronidase.
Authors
Christiaan Frederick Labuschagne
Owlstone Medical, Cambridge, United Kingdom
Christiaan Frederick Labuschagne , Rob Smith , Neelam Kumar , Max Allsworth , Billy Boyle , Sam Janes , Phil Crosbie , Robert Rintoul
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
New Targets and New Technologies (IO)
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2569)
DOI
10.1200/JCO.2022.40.16_suppl.2569
Abstract #
2569
Poster Bd #
224
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Early detection of lung cancer through programmatic management of pulmonary nodules in the Mississippi Delta.
First Author: Matthew Smeltzer
First Author: Amita Sharma
Poster
2021 ASCO Annual Meeting
Machine learning-based multiple cancer detections with circulating miRNA profiles in the blood.
First Author: Juntaro Matsuzaki
Poster
2014 ASCO Annual Meeting
Breath analysis as a noninvasive biomarker for early detection of lung cancer.
First Author: Nir Peled